The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- LACMTA Operators Benefit from Year of Safety Wins
- President Ferguson Responds to Washington Post
- Driverless Vehicles Raise Serious Concerns
- Merger Delay Does NOT Impact Jobs for Life Agreement
- Sister Robin Smith Shows What Solidarity Really Means
- Sens Josh Hawley and Tammy Baldwin Prove Again Why SMART-TD Endorsed
- Persistence and Creativity Secure Train Crew Privacy Protections in Indiana
- Notches Change, The Reverser DOESN’T
- A Legacy of Leadership: Sister Sandra Pineda Sets an Example Behind the Wheel and at Home
- New Railroad Safety Enhancement Act Builds Momentum